關於這一集
The evetn is part of the lecture series "Out of the Box: CRISPR/Cas". The lecture series reflects on the consequences of the revolutionary gene editing technology CRISPR/Cas in the fields of natural sciences and medicine, as well as its societal significance.
英語
美國
本 Podcast 中的其他單集
Genome editing gives precise control of the type of genetic modification made to a cell. Hematopoietic stem cells have pharmacologic properties of durability and output that still remain untapped. Matthew Porteus and his group are using genome editing of hematopoietic stem cells to develop new clas…
Sickle cell disease is one of the most prevalent diseases worldwide. Even optimal conventional care has demonstrated inferiority compared to curative options such as hematopoietic stem cell transplantation. Gene editing promises an elegant alternative cure to all patients lacking a matched donor, p…
The lecture series reflects on the consequences of the revolutionary gene editing technology CRISPR/Cas in the fields of natural sciences and medicine, as well as its societal significance. The top-class speakers of the series include Kay Davies (Oxford), Kevin M. Esvelt (MIT), Caroline Gutjahr (TU…
Panel discussion with Dr. Oana Dima, Prof. Dr. Caroline Gutjahr, and Prof. Dr. Kai P. Purnhagen | Moderation: Christoph von Eichhorn. The dicussion is the final event in the lecture series "Out of the Box: CRISPR/Cas".
The lecture series reflects on the consequences of the revolutionary gene editin…
The evetn is part of the lecture series "Out of the Box: CRISPR/Cas". The lecture series reflects on the consequences of the revolutionary gene editing technology CRISPR/Cas in the fields of natural sciences and medicine, as well as its societal significance.
免責聲明: 本頁面嵌入的 Podcast 和封面圖片來自 Center for Advanced Studies (CAS)，歸其所有者所有，與 Listen Notes, Inc. 無關聯，也未獲得 Listen Notes, Inc. 背書。
